Product Description: Aldafermin (NGM282) is an analog of fibroblast growth factor 19. Aldafermin can be used for the research of nonalcoholic steatohepatitis (NASH)[1].
Applications: Metabolism-protein/nucleotide metabolism
Formula: N/A
References: [1]Stephen A Harrison, et al. Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis. Gastroenterology. 2021 Jan;160(1):219-231.e1.
CAS Number: 1616639-03-2
Molecular Weight: N/A
Compound Purity: 97.63
Research Area: Metabolic Disease
Solubility: 10 mM in DMSO
Target: Others